Modern Diagnostic IPO Launch Today (GMP, Price Range & Lot Size)

MySandesh
3 Min Read
Abstract IPO icon

The IPO of Modern Diagnostic & Research Centre, a well-known diagnostics company, opens today and marks the last public issue of 2025.

Investors can place their bids until January 2, 2026. Here’s everything you need to know, explained in a simple and easy way.

Modern Diagnostic IPO: Key Details at a Glance

This IPO is a book-built issue.

The company plans to raise ₹36.89 crore by issuing 0.41 crore fresh shares.

There is no Offer for Sale (OFS), which means all the money raised will go directly to the company.

The price band for the IPO has been fixed at ₹85 to ₹90 per share.

GMP and Expected Listing Price

According to market tracker InvestorGain, Modern Diagnostic shares were trading at a grey market premium (GMP) of ₹10 on December 31.

Based on the upper price band of ₹90, the estimated listing price could be around ₹100 per share.

This suggests a possible gain of about 11.11% per share.

However, GMP is not an official indicator and can change at any time.

It does not guarantee profits or losses on listing day.

IPO Lot Size and Investor Requirements

One lot in this IPO consists of 1,600 shares.

Retail investors must apply for a minimum of two lots (3,200 shares), which requires an investment of ₹2.88 lakh at the upper price band.

HNI investors need to apply for at least three lots (4,800 shares), requiring an investment of ₹4.32 lakh.

Important IPO Dates to Remember

IPO opens: December 31, 2025

IPO closes: January 2, 2026

Share allotment: January 5, 2026

Refunds initiated: January 6, 2026

Shares credited to demat: January 6, 2026

  • Listing on BSE SME: January 7, 2026

About Modern Diagnostic & Research Centre

Modern Diagnostic & Research Centre is a growing diagnostics chain in India.

The company provides pathology and radiology services, including diagnostic tests, home sample collection, online reports, and customized test packages.

It currently operates 21 centres across eight states, including 18 laboratories and three diagnostic centres, catering to both individual patients and institutional clients.

Disclaimer


The information shared above is for informational purposes only.

Investing in the stock market involves risk.

Investors are advised to consult a certified financial expert before making any investment decisions.

The website does not recommend or endorse any investment.

Share This Article